Wegovy (semaglutide) Injector 1.7 mg/0.75 mL, 4 Pens Per Box is a medication used for chronic weight management in adults with obesity or excess weight who have at least one weight-related health condition, such as high blood pressure, type 2 diabetes, or high cholesterol. It is used in combination with a reduced calorie diet and increased physical activity. Wegovy is a glucagon-like peptide-1 (GLP-1) receptor antagonist and works by slowing down digestion, decreasing appetite, and increasing feelings of fullness, which helps with weight loss. It is administered as a subcutaneous injection and comes in a package of 4 pens for 4 weeks of treatment.

Wegovy is an extended-release injectable medication containing semaglutide, a medication that belongs to a class of drugs called GLP-1 receptor agonists. These drugs work by imitating the effects of a naturally occurring hormone in the body called glucagon-like peptide-1 (GLP-1).

GLP-1 is produced in the gut after we eat a meal and helps to lower blood sugar levels by stimulating the production of insulin and suppressing the release of the hormone glucagon. This leads to a decrease in the amount of glucose (sugar) that is released into the bloodstream from the liver and also an increase in the uptake of glucose into the body’s cells, where it is used as energy.

Additionally, GLP-1 can slow down the movement of food through the digestive tract, which helps to increase the feeling of fullness and reduce appetite. This can contribute to weight loss by reducing the amount of food consumed and by promoting feelings of satiety (fullness).

When semaglutide is injected with the Wegovy injector, it slowly releases the medication over the course of a week. This extended-release formulation allows for sustained and consistent levels of the medication to be in the body, providing better and longer-lasting effects and promoting weight loss and blood sugar control.